AstraZeneca PLC Celebrates More Than 35 Years Of Ongoing Patient Support Through Its Patient Assistance Programs

AZ&Me™ Prescription Savings Programs provided more than $670 million in savings to patients in the United States in 2014

WILMINGTON, Del.--(BUSINESS WIRE)--AstraZeneca (NYSE:AZN) is pleased to announce our ongoing support for patients through our longstanding patient assistance programs. In 2014 alone, the AZ&Me Prescription Savings Programs provided more than $670 million in savings to nearly 383,000 patients in the United States.

“As seen with the recent Supreme Court ruling to uphold healthcare subsidies, the discussions around healthcare in the United States continue to evolve. We remain committed to offering our patient assistance programs as this dialogue progresses”

“As seen with the recent Supreme Court ruling to uphold healthcare subsidies, the discussions around healthcare in the United States continue to evolve. We remain committed to offering our patient assistance programs as this dialogue progresses,” said Diane Sullivan, Vice President, Market Access & Patient Strategies. “We believe it’s not enough for us to simply make great medicines. We have to help ensure that the people who need those medicines have access to them.”

For more than 35 years, AstraZeneca has worked hard to better understand the needs of patients and the healthcare system so that our patient assistance programs can make a difference. We are committed to helping people get assistance affording their medicines—whether they’re our medicines or those made by someone else. This is why we also participate in multi-manufacturer programs like the Partnership for Prescription Assistance and support other organizations with the same goal—increasing access to medicines as well as healthcare.

AstraZeneca’s AZ&Me Prescription Savings Programs are designed to help qualifying people without insurance, those enrolled in Medicare Part D, those who receive their medications through participating healthcare facilities and those who have faced a financial challenge recently.

• Individuals without Prescription Drug Coverage: AstraZeneca provides free medicines to qualifying individuals with an annual income at or below $35,000 and families of four with an annual household income at or below $70,000.
• Part D Beneficiaries: AstraZeneca provides free medicines to qualifying Medicare Part D beneficiaries with an annual income at or below $35,000 and couples with an annual household income at or below $48,000.
• Healthcare Facilities: AstraZeneca provides free medicines to qualifying non-profit organizations, such as disproportionate share hospitals, community health centers and community free clinics. This program helps provide medicines to qualifying patients at the time and place of treatment.

About AstraZeneca

AstraZeneca is a global, innovation-driven biopharmaceutical business that focuses on the discovery, development and commercialization of prescription medicines, primarily for the treatment of cardiovascular, metabolic, respiratory, inflammation, autoimmune, oncology, infection and neuroscience diseases. AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide.

For more information about AstraZeneca in the United States, or our AZ&Me Prescription Savings Programs, please visit www.astrazeneca-us.com or call 1-800-AZandMe (292-6363).

AZ&Me is a trademark of the AstraZeneca group of companies. ©2015 AstraZeneca. All rights reserved.